Details of the Target
General Information of Target
Target ID | LDTP04357 | |||||
---|---|---|---|---|---|---|
Target Name | 5-hydroxytryptamine receptor 6 (HTR6) | |||||
Gene Name | HTR6 | |||||
Gene ID | 3362 | |||||
Synonyms |
5-hydroxytryptamine receptor 6; 5-HT-6; 5-HT6; Serotonin receptor 6 |
|||||
3D Structure | ||||||
Sequence |
MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNT
SNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLI SLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQC RLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVP RTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPG LFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGP RPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNF FNIDPAEPELRPHPLGIPTN |
|||||
Target Type |
Clinical trial
|
|||||
Target Bioclass |
GPCR
|
|||||
Family |
G-protein coupled receptor 1 family
|
|||||
Subcellular location |
Cell membrane
|
|||||
Function |
This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that stimulate adenylate cyclase. It has a high affinity for tricyclic psychotropic drugs. Controls pyramidal neurons migration during corticogenesis, through the regulation of CDK5 activity. Is an activator of TOR signaling.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
IA-alkyne Probe Info |
![]() |
N.A. | LDD0165 | [1] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Tyrosine-protein kinase Fyn (FYN) | Tyr protein kinase family | P06241 |
Other
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Microtubule-associated protein 1B (MAP1B) | MAP1 family | P46821 | |||
RNA-binding protein Nova-1 (NOVA1) | . | P51513 |
The Drug(s) Related To This Target
Approved
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Lu Ae58054 | Small molecular drug | D09IRN | |||
Sb-742457 | Small molecular drug | D0R9HI | |||
Avn 211 | . | D0WH4L |
Phase 2
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Avn-322 | Small molecular drug | DWD06K | |||
Bvt-74316 | Small molecular drug | D02KLD | |||
Prx-07034 | Small molecular drug | D03ZPX | |||
11c-gsk-215083 | . | D08PIK | |||
Abt-354 | . | D0X9HF |
Investigative
Patented
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Pmid30124346-compound-13table4 | Small molecular drug | D0F4NB | |||
Pmid30124346-compound-34table4 | Small molecular drug | D09BCJ |
Discontinued